글로벌 입자 치료 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 입자 치료 시장

입자 치료 시장은 2021년에서 2028년의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에서 언급한 예측 기간 동안 시장이 9.45%의 CAGR로 성장할 것으로 분석합니다. 광자 치료에 비해 입자 치료가 제공하는 이점이 증가함에 따라 입자 치료 시장이 성장합니다.

입자 치료는 암 치료를 위해 고에너지 중성자, 양이온 또는 양성자 빔을 사용하는 외부 빔 방사선 치료의 한 형태로 정의됩니다. 양성자 치료, 고속 중성자 치료, 탄소 이온 방사선 치료는 입자 치료의 다양한 방법 중 일부입니다.

전 세계적으로 암 유병률이 증가하는 것은 시장 성장을 가속화하는 중요한 요인이며, 임상 시험에서 입자 요법의 채택 증가, 전 세계적으로 입자 요법 센터 수 증가, 암 발생 증가 , 암 연구에 대한 투자 증가, 입자 요법 센터 및 임상 시험 수 증가는 입자 요법 시장을 주도하는 주요 요인 중 하나입니다. 또한 의료 기기의 기술적 진보와 현대화 증가, 의료 부문의 연구 개발 활동 증가, 노령 인구 기반이 증가하는 신흥 시장이 증가함에 따라 2021-2028년 예측 기간 동안 입자 요법 시장에 새로운 기회가 더욱 창출될 것입니다.

그러나 의료 시설의 인프라 문제 증가, 치료의 저렴성과 접근성 증가, 불리한 환불 정책 증가, 입자 치료에 대한 보험 적용 범위 제한 등이 시장 성장을 방해하는 주요 요인이며, 위에 언급한 예측 기간 동안 입자 치료 시장 성장을 더욱 어렵게 만들 것입니다 .

The particle therapy market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the particle therapy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Particle Therapy Market Scope and Market Size

The particle therapy market is segmented on the basis of therapy type, component type, system, cancer type and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of therapy type, the particle therapy market is segmented into proton therapy, heavy ion therapy and fast-neutron therapy.
• Based on component type, the particle therapy market is segmented into products and services. Products have been further segmented into cyclotrons, synchrotrons and synchrocyclotrons.
• Based on system, the particle therapy market is segmented into multi-room systems and single-room systems.
• Based on cancer type, the particle therapy market is segmented into prostate cancer, breast cancer, lung cancer, head and neck cancer and other cancers. Other cancers have been further segmented into lymphoma, sarcoma, spine cancer, pancreatic cancer, brain cancer, secondary/reoccurring cancer, gastrointestinal cancer and others.
• The particle therapy market is also segmented on the basis of application into treatment application and research application.

Particle Therapy Market Country Level Analysis

The particle therapy market is analysed and market size insights and trends are provided by country, therapy type, component type, system, cancer type and application as referenced above.

The countries covered in the particle therapy market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the particle therapy market due to increasing adoption of particle therapy in clinical trials, rising number of particle therapy centers worldwide, rising occurrences of cancer, increasing investment for cancer research and rising number of particle therapy centers and clinical trials in this region. Europe and Asia-Pacific are the expected region in terms of growth in particle therapy market due to rising per capita income, improving healthcare infrastructure, and increasing supportive government activities in countries such as China, Japan, and India

The country section of the particle therapy market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The particle therapy market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for particle therapy market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the particle therapy market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Particle Therapy Market Share Analysis

The particle therapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to the particle therapy market.

입자 치료 시장 보고서에 포함된 주요 기업으로는 Advanced Oncotherapy, IBA Worldwide, Accuray Incorporated, Brainlab, Elekta AB, Panacea, Shinva Medical Instrument Co. Ltd, xstrahl, Danfysik A/S, Hitachi Ltd., Mevion Medical Systems, Optivus Proton Therapy Inc., ProTom International, Provision Healthcare, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., SAH Global LLC, Mitsubishi Electric Corporation, Koninklijke Philips NV, PTW Freiburg GmbH 등이 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 각각 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-35946